Evidence map›Paper›PMID 37350345›Full record

ArticleRenal failure2023

Zero-contrast imaging for the assessment of transcatheter aortic valve implantation in candidates with renal dysfunction.

Guy F A Prado, Stefano Garzon, Jose Mariani, Adriano Caixeta, Breno O Almeida, Felipe O Ramalho, Marcelo L C Vieira, Claudio H Fischer, Gilberto Szarf, Walther Ishikawa and 1 more

Open access · goldAbstract read
In one paragraph

Article in Renal failure, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Guy F A PradoDepartment of Interventional Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil.ORCID 0000-0002-6942-355X
Stefano GarzonDepartment of Interventional Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil.ORCID 0000-0002-5705-4865
Jose MarianiDepartment of Interventional Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil.ORCID 0000-0002-0332-7530
Adriano CaixetaDepartment of Interventional Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil.ORCID 0000-0002-6287-5414
Breno O AlmeidaDepartment of Interventional Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil.ORCID 0000-0003-4436-7245
Felipe O RamalhoDepartment of Interventional Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Marcelo L C VieiraDepartment of Echocardiography, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Claudio H FischerDepartment of Echocardiography, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Gilberto SzarfDepartment of Radiology, Hospital Israelita Albert Einstein, São Paulo, Brazil.ORCID 0000-0002-1941-7899
Walther IshikawaDepartment of Radiology, Hospital Israelita Albert Einstein, São Paulo, Brazil.ORCID 0000-0002-5909-5126
Pedro A LemosDepartment of Interventional Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil.ORCID 0000-0002-6782-750X
Hospital Israelita Albert Einstein · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCandidates for transcatheter aortic valve implantation (TAVI) are currently evaluated using computed tomography angiography and invasive cardiac catheterization as an essential part of case selection and pre-procedure interventional planning. However, both imaging methods utilize iodinated agents, which may cause contrast-induced nephropathy, particularly in patients with baseline renal dysfunction. This study aimed to describe a zero-contrast imaging protocol for pre-TAVI evaluation in patients with advanced renal impairment.

methodsThe pre-TAVI zero-contrast scheme consisted of the following multi-modality combinations: (1) gadolinium-free magnetic resonance imaging (three-dimensional navigator-echo with electrocardiogram-gated steady-state free-precession series); (2) iodinated-free multislice computed tomography electrocardiogram-gated; (3) lower limb arterial duplex scan ultrasound; and (4) transesophageal echocardiography. Ultimately, TAVI was performed for those deemed good candidates, and contrast was allowed during the intervention; however, operators were strongly advised to utilize the least volume possible of iodinated agents. This pilot survey included ten patients with symptomatic aortic stenosis and renal dysfunction who underwent zero-contrast multi-modality imaging.

resultsAll the patients ultimately underwent TAVI. The intervention was successful in all cases, without ≥ moderate residual aortic regurgitation, prosthesis embolization, annulus rupture, major vascular complications, stroke, or death during index hospitalization. The creatinine clearance remained stable throughout the observation period (baseline: 26.85 ± 12.55 mL/min; after multi-modality imaging: 26.76 ± 11.51 mL/min; post-TAVI at discharge: 29.84 ± 13.98 mL/min;

conclusionThe proposed contrast-free imaging protocol appears to be a promising clinical tool for pre-TAVI evaluation in patients with severe renal dysfunction.

Indexed as

Aortic Valve StenosisHeart Valve ProsthesisHeart Valve Prosthesis ImplantationTranscatheter Aortic Valve ReplacementAortic ValveCardiac CatheterizationHumansMultidetector Computed TomographyAortic stenosiscontrast-induced nephropathyrenal failuretranscatheter aortic valve implantation

Identifiers

PMID37350345
PMCPMC10291906
OpenAlexW4381715850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.